Pharmacodynamics of TNF-α inhibitors in psoriasis. - Wikidata - wikimedia - TriplyDB

Pharmacodynamics of TNF-α inhibitors in psoriasis.

Pharmacodynamics of TNF-α inhibitors in psoriasis.

http://www.wikidata.org/entity/Q37960534

about

Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment.The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review.

P2860

Q34504431-F28921E4-DCFA-4D4D-9AC8-E0A3D38ECD86 Q54214331-FC5D23E0-C340-4CE5-B48C-1EEA96E9E44B

P2860

Pharmacodynamics of TNF-α inhibitors in psoriasis.

http://www.wikidata.org/entity/Q37960534

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@en

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@nl

type

label

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@en

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@nl

prefLabel

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@en

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@nl

P1433

Q37960534-8E3EAA5D-39DC-4147-A303-EDFA8E97472A

P1476

Q37960534-2BA13166-AEC9-4CD5-8E1D-19179B7E10A9

P2093

Q37960534-681E2209-8B8D-41C9-B039-152173AE4240

Q37960534-8EC6A3EF-452F-45C7-842C-E9C7AF8CA7A9

Q37960534-94556E58-162A-4C23-B337-423BFC3E42E7

Q37960534-9B96CDCC-0AB7-492E-89C4-E4271B89B453

Q37960534-AEDC759C-B689-4123-8059-A813B0AA1104

P2860

Q37960534-1E2CCD91-1FAA-4120-A8A3-F05C2780DED8

Q37960534-1FDB8A36-0666-463B-97F3-1A5B8F8A88B7

Q37960534-375FD249-1BBF-47D8-9399-4F0C12B5F5A0

Q37960534-3A9FA1CF-4C45-4B09-B53C-DDD44D4A6020

Q37960534-430711B8-842D-4E57-BDF3-0A8DFA073E52

Q37960534-4AB88954-9BC6-456C-A424-AC12A555440F

Q37960534-5CD2034A-204F-4844-9227-518B418ACFE2

Q37960534-5D14A577-BD77-49BC-9227-6B382BB3D770

Q37960534-5E0435FC-3FF1-432B-AB10-D4B96FC5DAFC

Q37960534-62CD4ABE-78D7-4CDC-B320-46AAF6F72547

P304

Q37960534-4D3AADB6-8C0F-4AF7-B96E-3F5A3722B852

P31

Q37960534-E6CC7CDD-631F-43E9-A697-5683B100E41B

P356

Q37960534-4EE2608D-68D8-4011-9C1D-75A18355A3C8

P407

Q37960534-F7687BC6-7840-4667-9AE2-C5299F1AF992

P433

Q37960534-3D5CFF7D-15CB-4583-91B6-77E85E5B72B3

P478

Q37960534-2F2B8046-8021-487D-8BF7-495143000A9A

P577

Q37960534-9564EA7B-93A3-49B4-ABE0-FC1AD96EAE21

P698

Q37960534-52455D5D-15C0-46AF-9B13-F6A558B74878

P921

Q37960534-E8AFE5EF-614F-454B-B102-FFBAAB9DE1BF

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Pharmacodynamics of TNF-α inhibitors in psoriasis.

@en

P2093

Aikaterini-Evangelia Moustou

http://www.w3.org/2001/XMLSchema#string

Alexander J Stratigos

http://www.w3.org/2001/XMLSchema#string

Christina Antoniou

http://www.w3.org/2001/XMLSchema#string

Petros P Sfikakis

http://www.w3.org/2001/XMLSchema#string

Theognosia Vergou

http://www.w3.org/2001/XMLSchema#string

P2860

The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore.

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.

Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.

The immunologic basis for the treatment of psoriasis with new biologic agents.

P304

515-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.11.28

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22114860

http://www.w3.org/2001/XMLSchema#string

P921